Clinical Trials Browser

Non-Muscle Invasive Bladder Neoplasms × enzalutamide × Genitourinary × Clear all

NCT02605863 2018-10-03

Enzalutamide for Bladder Cancer Chemoprevention

Phase 2 Terminated

1 enrolled 6 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms